首页> 美国卫生研究院文献>Avicenna Journal of Medical Biotechnology >Characterization of Monoclonal and Polyclonal Antibodies Recognizing Prostate Specific Antigen: Implication for Design of a Sandwich ELISA
【2h】

Characterization of Monoclonal and Polyclonal Antibodies Recognizing Prostate Specific Antigen: Implication for Design of a Sandwich ELISA

机译:识别前列腺特异性抗原的单克隆和多克隆抗体的表征:对夹心ELISA设计的启示

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background:Prostate cancer is the second most common cancer in men. Prostate-Specific Antigen (PSA) is a tumor-associated glycoprotein with enzymatic activity which is secreted by the prostate gland. Following entry to the blood, 70–90% of PSA forms complexes with protease inhibitors and its enzymatic activity is inhibited. The serum level of PSA is increased and the rate of free PSA (fPSA) to total PSA is decreased in prostate cancer patients. Therefore, measurement of PSA and fPSA in serum is very valuable for diagnosis and prognosis of prostate cancer.
机译:背景:前列腺癌是男性中第二大最常见的癌症。前列腺特异性抗原(PSA)是一种具有肿瘤酶活性的肿瘤相关糖蛋白,由前列腺分泌。进入血液后,70-90%的PSA与蛋白酶抑制剂形成复合物,其酶活性被抑制。前列腺癌患者的血清PSA水平升高,游离PSA(fPSA)占总PSA的比率降低。因此,血清中PSA和fPSA的测定对前列腺癌的诊断和预后非常有价值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号